Protecting and Preserving Social Security ActThis bill eliminates the cap on income subject to Social Security taxes and revises methods for calculating various aspects of Social Security benefits.Under current law, Social Security has a taxable maximum, which refers to the maximum amount of a worker's earnings that are subject to Social Security payroll taxes (set at $176,100 in 2025). The taxable maximum also serves as the maximum amount of earnings used to calculate a worker's Social Security benefits.This bill phases out the taxable maximum so as to apply payroll taxes to all earnings after 2031, and revises the method used to calculate a worker’s Social Security benefits to account for earnings in excess of the taxable maximum.The bill also revises the method of calculating cost-of-living adjustments to Social Security benefits to reflect the spending habits of individuals over the age of 62. An increase in Social Security benefits resulting from this change may not be treated as income for purposes of determining eligibility for, or the amount of assistance provided under, the Medicaid or Supplemental Security Income programs.

A bill to require the Director of the National Institute of Standards and Technology to develop voluntary guidelines and specifications for internal and external assurances of artificial intelligence systems, and for other purposes.

A bill to amend the Act of October 19, 1973, to increase the maximum dollar amount of per capita shares for purposes of eligibility for financial assistance or other benefits under Federal or federally assisted programs, and for other purposes.

Reducing Drug Prices for Seniors ActThis bill requires the coinsurance amount for covered drugs under the Medicare prescription drug benefit to be based on the net price of the drug (i.e., the negotiated price under the prescription drug plan net of any manufacturer price concessions), rather than the list price of the drug, if the net price is lower.

A bill to improve the process for awarding grants under certain programs of the Department of Agriculture to certain counties in which the majority of land is owned or managed by the Federal Government and to other units of local government and Tribal governments in those counties, and for other purposes.

A bill to improve the process for awarding grants under certain programs of the Department of Transportation to certain counties in which the majority of land is owned or managed by the Federal Government and to other units of local government and Tribal governments in those counties, and for other purposes.

Reforming Evergreening and Manipulation that Extends Drug Years Act or the REMEDY ActThis bill limits the scope of a 30-month stay on approval of a generic drug by the Food and Drug Administration (FDA) while patent litigation involving the reference (brand-name) drug is ongoing.Generally, entities seeking approval of a new drug must provide the FDA with information on patents claiming the drug or a method of use. Entities seeking approval of a generic drug must certify for each such patent on the reference drug that (1) the patent has expired or will expire before the generic is marketed, or (2) the patent is invalid or inapplicable to the generic drug. If a generic drug applicant certifies that a patent is invalid or inapplicable and a patent infringement suit is timely brought, the FDA is prohibited from approving the generic for 30 months (unless the patent litigation is resolved sooner). Under current law, this 30-month stay applies to patent litigation on any number of patents on a reference drug, provided the patent information was filed with the FDA before the generic application.Under the bill, when an entity applies to the FDA for approval of a new drug, the entity must select only one patent to be eligible for the 30-month stay. This selection may not be changed or amended. After the bill’s enactment, only patent litigation related to the reference drug’s selected patent may trigger the 30-month stay on approval of a generic.

A bill to amend the Public Health Service Act to reauthorize support for State-based maternal mortality review committees, to direct the Secretary of Health and Human Services to disseminate best practices on maternal mortality prevention to hospitals, State-based professional societies, and perinatal quality collaboratives, and for other purposes.

A bill to authorize the Administrator of the National Aeronautics and Space Administration to conduct a pilot program for investment in infrastructure projects at the Kennedy Space Center and to establish the Infrastructure Investment Fund, and for other purposes.

A bill to enhance the transparency of the National Cemetery Administration of the Department of Veterans Affairs, and for other purposes.

Medicaid Bump Act This bill increases the Medicaid federal matching rate, also known as the Federal Medical Assistance Percentage (FMAP), for behavioral health expenses that exceed prior levels (i.e., as of March 31, 2019). The Centers for Medicare & Medicaid Services must specify which services are eligible for the increased FMAP. States must use funds to supplement state funding for programs in effect as of April 1, 2021, and to increase the capacity, efficiency, and quality of services.

A bill to amend the Small Business Investment Act of 1958 to establish the Scale-Up Manufacturing Investment Company ("SUMIC") Program.

A bill to amend title 38, United States Code, to reform the requirements and authorities of the Director of Construction and Facilities Management of the Department of Veterans Affairs and to reform the acquisition, procurement, logistics, leasing, and construction activities of the Department, and for other purposes.

A bill to amend title 18, United States Code, to assert jurisdiction over murders committed by certain inadmissible or deportable aliens.

A bill to update the definition of manufactured home, and for other purposes.